Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.
Saved in:
| Title: | Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study. |
|---|---|
| Authors: | Walker A; GSK, Stevenage, UK., Erwig L; GSK, Stevenage, UK., Foster K; GSK, Stevenage, UK., Nevin K; GSK, Stevenage, UK., Wenzel J; University Hospital of Bonn, Bonn, Germany., Worm M; Division of Allergy and Immunology, Department of Dermatology, Venerology and Allergy, Charité, Berlin, Germany., Williams N; GSK, Stevenage, UK., Ratia N; GSK, Stevenage, UK., Hoang B; GSK, Collegeville, PA, USA., Schneider-Merck T; GSK, Hamburg, Germany., Gisbert S; GSK, Uxbridge, UK., Carnarius H; GSK, Hamburg, Germany., Dickson M; GSK, Stevenage, UK. |
| Source: | Experimental dermatology [Exp Dermatol] 2021 Nov; Vol. 30 (11), pp. 1686-1692. Date of Electronic Publication: 2020 Dec 17. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Munksgaard Country of Publication: Denmark NLM ID: 9301549 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0625 (Electronic) Linking ISSN: 09066705 NLM ISO Abbreviation: Exp Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1600-0625 |
|---|---|
| DOI: | 10.1111/exd.14253 |
